[HTML][HTML] Exogenous NO therapy for the treatment and prevention of atherosclerosis
T Gori - International Journal of Molecular Sciences, 2020 - mdpi.com
Amyl nitrite was introduced in 1867 as the first molecule of a new class of agents for the
treatment of angina pectoris. In the following 150 years, the nitric oxide pathway has been …
treatment of angina pectoris. In the following 150 years, the nitric oxide pathway has been …
Exogenous NO Therapy for the Treatment and Prevention of Atherosclerosis.
T Gori - International Journal of Molecular Sciences, 2020 - search.ebscohost.com
Amyl nitrite was introduced in 1867 as the first molecule of a new class of agents for the
treatment of angina pectoris. In the following 150 years, the nitric oxide pathway has been …
treatment of angina pectoris. In the following 150 years, the nitric oxide pathway has been …
[PDF][PDF] Exogenous NO Therapy for the Treatment and Prevention of Atherosclerosis
T Gori - Int. J. Mol. Sci, 2020 - pdfs.semanticscholar.org
Amyl nitrite was introduced in 1867 as the first molecule of a new class of agents for the
treatment of angina pectoris. In the following 150 years, the nitric oxide pathway has been …
treatment of angina pectoris. In the following 150 years, the nitric oxide pathway has been …
Exogenous NO Therapy for the Treatment and Prevention of Atherosclerosis
T Gori - International Journal of Molecular Sciences, 2020 - search.proquest.com
Amyl nitrite was introduced in 1867 as the first molecule of a new class of agents for the
treatment of angina pectoris. In the following 150 years, the nitric oxide pathway has been …
treatment of angina pectoris. In the following 150 years, the nitric oxide pathway has been …
Exogenous NO Therapy for the Treatment and Prevention of Atherosclerosis.
T Gori - International Journal of Molecular Sciences, 2020 - europepmc.org
Amyl nitrite was introduced in 1867 as the first molecule of a new class of agents for the
treatment of angina pectoris. In the following 150 years, the nitric oxide pathway has been …
treatment of angina pectoris. In the following 150 years, the nitric oxide pathway has been …
Exogenous NO Therapy for the Treatment and Prevention of Atherosclerosis
T Gori - 2020 - agris.fao.org
Amyl nitrite was introduced in 1867 as the first molecule of a new class of agents for the
treatment of angina pectoris. In the following 150 years, the nitric oxide pathway has been …
treatment of angina pectoris. In the following 150 years, the nitric oxide pathway has been …
[HTML][HTML] Exogenous NO Therapy for the Treatment and Prevention of Atherosclerosis
T Gori - International Journal of Molecular Sciences, 2020 - ncbi.nlm.nih.gov
Amyl nitrite was introduced in 1867 as the first molecule of a new class of agents for the
treatment of angina pectoris. In the following 150 years, the nitric oxide pathway has been …
treatment of angina pectoris. In the following 150 years, the nitric oxide pathway has been …
Exogenous NO Therapy for the Treatment and Prevention of Atherosclerosis
T Gori - International Journal of Molecular Sciences, 2020 - hero.epa.gov
Amyl nitrite was introduced in 1867 as the first molecule of a new class of agents for the
treatment of angina pectoris. In the following 150 years, the nitric oxide pathway has been …
treatment of angina pectoris. In the following 150 years, the nitric oxide pathway has been …
Exogenous NO Therapy for the Treatment and Prevention of Atherosclerosis
T Gori - International journal of molecular sciences, 2020 - pubmed.ncbi.nlm.nih.gov
Amyl nitrite was introduced in 1867 as the first molecule of a new class of agents for the
treatment of angina pectoris. In the following 150 years, the nitric oxide pathway has been …
treatment of angina pectoris. In the following 150 years, the nitric oxide pathway has been …